Table 1. Clinical and pathological characteristics in relation to SUVmax in patients with NSCLC.
Characteristic | No. patients | SUVmax | P-value |
Age | |||
60 years | 39 | 6.85±3.81 | 0.58 |
60 years | 40 | 7.42±4.23 | |
Gender | 0.37 | ||
Male | 50 | 7.65±4.27 | |
Female | 29 | 6.54±4.84 | |
Tumor size (cm) | <0.01 | ||
≤3.0 | 54 | 5.62±3.82 | |
>3.0 | 25 | 10.7±4.18 | |
Pathology | <0.01 | ||
Squamous | 24 | 10.60±4.73 | |
Adenocarcinoma | 55 | 5.94±4.04 | |
Tumor differentiation | <0.01 | ||
Well | 13 | 4.4±3.1 | |
Moderate | 34 | 7.2±4.2 | |
Poor | 32 | 12.7±4.1 | |
Pathological N stage | <0.01 | ||
N0 | 55 | 6.33±4.60 | |
N1 | 24 | 9.31±3.89 | |
Outcome | <0.01 | ||
Alive | 42 | 6.13±3.89 | |
Dead | 20 | 9.66±4.15 |
SUVmax = maximal standardized uptake value.